Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: Identification of two novel proteins, BCNP1 and MIG2B

Leukemia

Volumn 17, Issue 8, 2003, Pages 1605-1612

  Boyd, R S ^a   Adam, P J ^a   Patel, S ^a   Loader, J A ^a   Berry, J ^a   Redpath, N T ^a   Poyser, H R ^a   Fletcher, G C ^a   Burgess, N A ^a   Stamps, A C ^a   Hudson, L ^a   Smith, P ^a   Griffiths, M ^a   Willis, T G ^b   Karran, E L ^b,c   Oscier, D G ^d   Catovsky, D ^b   Terrett, J A ^a   Dyer, M J S ^b,c  

^a Oxford GlycoSciences (UK) Ltd   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukemia; Plasma membrane; Proteomics

Indexed keywords

CELL SURFACE RECEPTOR; EZRIN; INTEGRIN; MEMBRANE ANTIGEN; MEMBRANE ENZYME; MEMBRANE PROTEIN; MOESIN; PLECKSTRIN; PROTEIN BCNP1; PROTEIN MIG2B; RADIXIN; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CAENORHABDITIS ELEGANS; CELL ADHESION; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METHODOLOGY; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; PROTEOMICS; SEQUENCE HOMOLOGY;

EID: 0042527712     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402993     Document Type: Article

References (21)

1. Rozman C, Montserrat E. Current concepts: chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-1057.
2. Kalil N, Cheson BD. Chronic lymphocytic leukemia. Oncologist 1999; 4: 352-369.
3. Aalto Y, El-Rifai W, Vilpo L, Ollila J, Nagy B, Vihinen M et al. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 2001; 15: 1721-1728.
4. Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N et al. CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001; 91: 474-480.
5. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002; 99: 4554-4561.
6. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
7. Voss T, Ahorn H, Harbel P, Wilgenbus K. Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int J Cancer 2000; 91: 180-186.
8. Pasquali C, Fialka I, Huber L-A. Subcellular fractionation, electromigration analysis and mapping of organelles. J Chromatogr B Biomed Sci Appl 1999; 722: 89-102.
9. Eng J-K, McCormack A-L, Yates III J-R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein. J Am Soc Mass Spectrom 1994; 5: 976-989.
10. Boyd RS, Duggan MJ, Shone CC, Foster KA. The effect of botulinum neurotoxins on the release of insulin from the insulinoma cell lines HIT-15 and RINm5F. J Biol Chem 1995; 270: 18216-18218.
11. Pappin DJC, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide mass fingerprinting. Curr Biol 1993; 3: 327-332, also http://www.hgmp.mrc.ac.uk/Bioinformatics/Webapp/mowse.
12. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 2003; 278: 6482-6489.
13. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI. Immunotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 2001; 61: 4483-4489.
14. Hulkkonen J, Vilpo L, Hurme M, Vilpo J. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. Leukemia 2002; 16: 178-185.
15. Treumann A, Lifely MR, Schneider P, Ferguson MA. Primary structure of CD52. J Biol Chem 1995; 270: 6088-6099.
16. Burge C, Karlin S. Prediction of complete gene structures in human genomic DNA. J Mol Biol 1997; 268: 78-94.
17. Venkataraman C, Muthusamy N, Muthukkumar S, Bondada S. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. J Immunol 1998; 160: 3322-3329.
18. Majima S, Kajino K, Fukuda T, Otsuka F, Hino O. A novel gene 'Niban' upregulated in renal carcinogenesis cloning by the cDNA-amplified fragment length polymorphis approach. Jpn J Cancer Res 2000; 91: 869-874.
19. Wick M, Burger C, Brusselbach S, Lucibello FC, Muller R. Identification of serum-inducible genes: different patterns of gene regulation during G0→S and G1→S progression. J Cell Sci 1994; 107: 227-239.
20. Rogalski TM, Mullen GP, Gilbert MM, Williams BD, Moerman DG. The UNC-112 gene in Caenorhabditis elegans encodes a novel component of the cell-matrix adhesion structures required for integrin localization in the muscle membrane. J Cell Biol 2000; 150: 253-264.
21. Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD. C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 2002; 14: 787-797.